*By Carlo Versano*
The world's largest beverage maker is reportedly eyeing the red-hot cannabis market, according to a [report] (https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528).
Coca-Cola is in "serious talks" with Aurora Cannabis to develop cannabidiol-infused beverages, according to BNN Bloomberg.
A deal on that scale would likely dwarf agreements made by Corona-maker Constellation Brands and Molson Coors, both of which have partnered with Canadian cannabis companies to add CBD, the non-psychoactive ingredient in cannabis that can be used to treat pain or anxiety, to drinks like coffee, soda, and beer, and would represent a "mainstreaming" of pot products in the eyes of Wall Street.
For Coke, getting into the weed market would be both capturing a trend and a diversification play. Soda sales have been down as younger consumers seek out healthier drinks like sparkling water.
Shares of Aurora were up over 6 percent on the news Monday morning, as were other pot stocks like Tilray.
The U.S. economy added 272,000 jobs in May, far more than expected. But that number doesn't tell the whole story. Interest rate cuts could still be on the way.
The AI boom is heating up worldwide competition, the NBA is cashing in, and short-selling is (surprise!) risky. Plus, who are this week's Usual Suspects?
A.I. Reporter at The Verge, Kylie Robison, joins Cheddar to discuss everything you need to know about artificial intelligence, from Nvidia to Musk and OpenAI.
